Nika BioTechnology, Inc. (NIKA)
USD 0.51
(0.0%)
USD 0.51
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 85.21 Thousand | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | 85.21 Thousand | - | - | - |
| Operating Expenses | 64.83 Thousand | 69.62 Thousand | 244.88 Thousand | 6500.00 | 6500.00 | 33.39 Thousand |
| Selling, General and Administrative Expenses | 64.83 Thousand | 69.62 Thousand | 244.88 Thousand | 6500.00 | 6500.00 | 33.39 Thousand |
| Research and Development Expenses | - | 3 Million | - | - | - | - |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 64.83 Thousand | 69.62 Thousand | 244.88 Thousand | 6500.00 | 6500.00 | 33.39 Thousand |
| Operating Income | -64.83 Thousand | -69.63 Thousand | -159.67 Thousand | -6500.00 | -6500.00 | -33.39 Thousand |
| Interest Expense | - | - | 3489.00 | 115.00 | 147.00 | 364.00 |
| Income Tax Expense | - | -3.18 Million | -14.71 Thousand | -8907.00 | -171.86 Thousand | - |
| Earnings before Tax | -64.83 Thousand | -69.62 Thousand | -160.97 Thousand | -6615.00 | -6647.00 | -33.75 Thousand |
| Net Income | -64.83 Thousand | -69.62 Thousand | -160.97 Thousand | -6615.00 | -6647.00 | -33.75 Thousand |
| Earnings Per Share Basic | -0.00 | -0.00 | -0.00 | - | - | -0.01 |
| Earnings Per Share Diluted | -0.00 | -0.00 | -0.00 | - | - | -0.01 |
| Weighted Average Shares Outstanding | 876.12 Million | 876.09 Million | 876.09 Million | 876.09 Million | 876.09 Million | 2.55 Million |
| Weighted Average Shares Outstanding (Diluted) | 876.09 Million | 876.09 Million | 876.09 Million | 876.09 Million | 876.09 Million | 2.55 Million |
| Gross Margin | - | - | 1.00 | - | - | - |
| EBIT Margin | - | - | -1.87 | - | - | - |
| Profit Margin | - | - | -1.89 | - | - | - |
| EBITDA | -64.83 Thousand | - | - | - | -6500.00 | -33.39 Thousand |
| Earnings Before Tax Margin | - | - | -1.87 | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 156.00 | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | 156.00 | - | - | - | - | - |
| Operating Expenses | 54.95 Thousand | 65.98 Thousand | 64.83 Thousand | 7314.00 | 2100.00 | 4960.00 |
| Selling, General and Administrative Expenses | 54.95 Thousand | 65.98 Thousand | - | 7314.00 | 2100.00 | 4960.00 |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 54.95 Thousand | 65.98 Thousand | 64.83 Thousand | 7314.00 | 2100.00 | 4960.00 |
| Operating Income | -54.8 Thousand | -65.98 Thousand | -64.83 Thousand | -7314.00 | -2100.00 | -4960.00 |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | -54.8 Thousand | -43.27 Thousand | -64.83 Thousand | - | -10.14 Thousand | -27.8 Thousand |
| Earnings before Tax | -54.8 Thousand | -65.98 Thousand | -64.83 Thousand | -7314.00 | -2100.00 | -4960.00 |
| Net Income | -54.8 Thousand | -65.98 Thousand | -64.83 Thousand | -7314.00 | -2100.00 | -4960.00 |
| Earnings Per Share Basic | -0.00 | -0.00 | - | - | - | - |
| Earnings Per Share Diluted | -0.00 | -0.00 | - | - | - | - |
| Weighted Average Shares Outstanding | 1.01 Billion | 876.09 Million | 816.82 Million | 914.25 Million | 816.82 Million | 876.09 Million |
| Weighted Average Shares Outstanding (Diluted) | 1.01 Billion | 876.09 Million | 816.82 Million | 876.09 Million | 816.82 Million | 876.09 Million |
| Gross Margin | 1.00 | - | - | - | - | - |
| EBIT Margin | -351.28 | - | - | - | - | - |
| Profit Margin | -351.28 | - | - | - | - | - |
| EBITDA | -54.8 Thousand | -65.98 Thousand | - | - | -2100.00 | -4960.00 |
| Earnings Before Tax Margin | -351.28 | - | - | - | - | - |
IMAQW
BMBRF
YUKA
LWCL
ADMCM
6443